Literature DB >> 25750336

Prognostic factor of severe complications in patients with hypopharyngeal cancer with primary concurrent chemoradiotherapy.

Liang-Yu Chen1, Chia-Chang Huang1, Yung-An Tsou2, Da-Tian Bau3, Ming-Hsui Tsai2.   

Abstract

BACKGROUND/AIM: Organ-preservation treatment for hypopharyngeal cancer has recently become a popular treatment option. However, the severe complications and poor quality of life after non-surgical treatment should be avoided. We accessed the laryngeal or pharyngeal dysfunction-related complications after concurrent chemoradiotherapy (CCRT) as the primary treatment for hypopharyngeal cancer. PATIENTS AND METHODS: Data concerning all patients treated for hypopharyngeal cancer with primary non-surgical treatment at the China Medical University Hospital from 2002 to 2012 were retrospectively reviewed.
RESULTS: A total of 161 patients were included with a median age of 56.6 years. The disease control rates (disease-free >12 months) and severe complication rates were correlated to the tumor (T) stage and nodal (N) stage. In the successful treatment group, the complication rate was related to the N stage. The overall pharyngeal dysfunction, laryngeal dysfunction and aspiration rates were 36%, 27% and 25%, respectively. For patients with T4a disease, hyoid bone invasion significantly increased the severe complication rate (p=0.0212).
CONCLUSION: The treatment outcome was correlated to the T and N stage. A higher rate of laryngopharyngeal dysfunction occurred when treating hyoid bone invasion in T4a patients with primary non-surgical treatment. In advanced stage, but still resectable hypopharyngeal tumors, the poorer quality of life due to non-function larynx was noted after treating with CCRT. Copyright
© 2015 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved.

Entities:  

Keywords:  Hypopharyngeal cancer; chemoradiotherapy; complication; hyoid bone; larynx preservation

Mesh:

Year:  2015        PMID: 25750336

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  6 in total

1.  Modified TALK Score for Japanese Patients with Laryngeal and Hypopharyngeal Cancers to Predict the Possibility of Laryngeal Preservation by Concurrent Chemoradiotherapy.

Authors:  Naoki Otsuki; Mio Matsui; Miki Takahashi; Ryohei Sasaki; Naomi Kiyota; Makoto Usami; Ken-Ichi Nibu
Journal:  Kobe J Med Sci       Date:  2018-04-19

2.  A Survival Analysis of Hypopharyngeal Cancer Patients: A Hospital-Cancer registry Based Study.

Authors:  Manigreeva Krishnatreya; Amal Chandra Kataki; Jagannath Dev Sharma; Nizara Baishya; Tashnin Rahman; Mouchumee Bhattcharyya; Ashok Kumar Das; Manoj Kalita
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2018-12-27

3.  Oncological and functional outcomes of transoral laser surgery for hypopharyngeal carcinoma.

Authors:  Rodrigo Casanueva; Fernando López; Patricia García-Cabo; César Álvarez-Marcos; José Luis Llorente; Juan Pablo Rodrigo
Journal:  Eur Arch Otorhinolaryngol       Date:  2022-09-03       Impact factor: 3.236

Review 4.  Systematic review and meta-analysis of transoral laser microsurgery in hypopharyngeal carcinoma.

Authors:  Ciaran Lane; Rasheda Rabbani; Janice Linton; S Mark Taylor; Norbert Viallet
Journal:  Laryngoscope Investig Otolaryngol       Date:  2020-01-14

5.  Treatment patterns and survival outcomes of advanced hypopharyngeal squamous cell carcinoma.

Authors:  Yao-Te Tsai; Wen-Cheng Chen; Chih-Yen Chien; Cheng-Ming Hsu; Yi-Chan Lee; Ming-Shao Tsai; Meng-Hung Lin; Chia-Hsuan Lai; Kai-Ping Chang
Journal:  World J Surg Oncol       Date:  2020-05-01       Impact factor: 2.754

6.  The presence of risk factors and corresponding treatment strategies post-surgical resection in stage IV hypopharyngeal squamous cell carcinoma patients: a retrospective cohort study.

Authors:  Yu Heng; Xiaoke Zhu; Liang Zhou; Ming Zhang; Hong Zhou; Lei Tao
Journal:  Ann Transl Med       Date:  2020-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.